Tirzepatide
Dual Receptor Agonist Peptide for Metabolic & Endocrine Signaling Research
- Third-party tested
- COA available
- Lyophilized research material
Description
Tirzepatide is a synthetic peptide investigated for simultaneous activity at two incretin receptors: GIPR and GLP-1R. Its dual-receptor profile has made it an important compound in metabolic and endocrine signaling research.
$90.00/ 10 mg · USD
Volume pricing
Applied automatically in the cart
| Quantity | Per unit | You save |
|---|---|---|
| 3–4 units | $85.50 | −5% |
| 5–9 units | $81.00 | −10% |
| 10+ units | $76.50 | −15% |
Add 2 more to save 5% on every unit.
SKU VP-TIRZ-10
Lab search code Viop2610060531
Purity stated per lot
Figures are reported against the lot they belong to, never as a brand average. The analysis for a batch is published on that batch’s certificate.
- Certificate published for each batch
- Third-party tested
- Orders over $200 ship free
- Supplied for laboratory research use only
Complete your protocol
Lyophilized vials are supplied dry. Add the accompanying laboratory supplies in one step.
- TirzepatideThis item
Nothing selected
$0.00
Supplied as laboratory materials for research use only.
Scientific overview
Tirzepatide is commonly classified as a GIP/GLP-1 receptor dual agonist. Unlike single-receptor experimental compounds, Tirzepatide has been designed to interact with two distinct incretin receptor systems. GIPR, the Glucose-Dependent Insulinotropic Polypeptide Receptor, is investigated in incretin biology, nutrient signaling, and metabolic communication. GLP-1R, the Glucagon-Like Peptide-1 Receptor, is studied in glucose-dependent endocrine signaling, nutrient sensing, pancreatic signaling, and central metabolic pathways. Its dual-receptor activity allows researchers to investigate how two incretin pathways interact within the same experimental model.
Research applications
- GIP receptor signaling
- GLP-1 receptor signaling
- Dual-agonist pharmacology
- Incretin biology
- Metabolic signaling
- Nutrient-sensing pathways
- Endocrine communication
- Cellular receptor activation
- Energy-homeostasis research
Research use & regulatory disclaimer
All products offered by viopep are intended solely for laboratory research and analytical purposes. viopep products are not intended for human or veterinary use or consumption.
Products offered by viopep have not been approved by the U.S. Food and Drug Administration (FDA) for the diagnosis, treatment, cure, mitigation, or prevention of any disease or medical condition. Products are not intended to be used as drugs, food products, dietary supplements, cosmetics, or household products.
Information provided on this website is for general informational and research purposes only. Nothing on this website is intended to constitute medical advice, diagnosis, treatment recommendations, dosing instructions, or guidance regarding human or veterinary use.
By purchasing from viopep, the purchaser acknowledges that products are intended solely for legitimate research purposes and agrees to use and handle all products in accordance with applicable laws, regulations, and appropriate laboratory safety procedures.
Specifications
| Compound | Tirzepatide |
|---|---|
| Compound Type | Synthetic peptide |
| Primary Targets | GIPR / GLP-1R |
| Research Category | Metabolic & Endocrine Signaling |
| Catalog strengths | 10 mg / 20 mg / 40 mg |
| SKU | VP-TIRZ-10 / VP-TIRZ-20 / VP-TIRZ-40 |
| Purity | Published on the certificate for each batch |
| Analytical method | Published on the certificate for each batch |
| Testing laboratory | Published on the certificate for each batch |
| Form | Lyophilized research material |
Storage and handling
Store lyophilized at -20°C; protect from light and moisture. Reconstitute with bacteriostatic water; refrigerate reconstituted solution at 2-8°C.